107th ENMC International Workshop: The management of cardiac involvement in muscular dystrophy and myotonic dystrophy. 7th-9th June 2002, Naarden, the Netherlands

Neuromuscular Disorders

Volumn 13, Issue 2, 2003, Pages 166-172

  Bushby, K ^a   Muntoni, F ^a   Bourke, J P ^a  

^a INSTITUTE OF HUMAN GENETICS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIARRHYTHMIC AGENT; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DYSTROPHIN; STEROID; WARFARIN;

ARTIFICIAL HEART PACEMAKER; ATRIOVENTRICULAR BLOCK; BECKER MUSCULAR DYSTROPHY; CONFERENCE PAPER; DEFIBRILLATOR; DISEASE CARRIER; DUCHENNE MUSCULAR DYSTROPHY; ECG ABNORMALITY; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; EMERY DREIFUSS MUSCULAR DYSTROPHY; FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY; HEART ATRIUM ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART ATRIUM FLUTTER; HEART DILATATION; HEART DISEASE; HEART FUNCTION TEST; HEART MUSCLE CONDUCTION DISTURBANCE; HEART TRANSPLANTATION; HOLTER MONITORING; HUMAN; LIMB GIRDLE MUSCULAR DYSTROPHY; MUSCULAR DYSTROPHY; MYOTONIC DYSTROPHY; NETHERLANDS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RESPIRATORY FAILURE; SCOLIOSIS; STEROID THERAPY;

EID: 0037304994     PISSN: 09608966     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-8966(02)00213-4     Document Type: Article

References (83)

1. Heymsfield S.B., McNish T., Perkins J.V., et al. Sequence of cardiac changes in Duchenne muscular dystrophy. Am Heart J. 95:1978;283-294.
2. de Kermadec J.M., Becane H.M., Chenard A., et al. Prevalence of left ventricular systolic dysfunction in Duchenne muscular dystrophy: An echocardiographic study. Am Heart J. 127:1994;618-623.
3. Corrado G., Lissoni A., Beretta S., et al. Prognositc value of electrocardiograms, ventricular late potentials, ventricular arrhythmias and left ventricular systolic dysfunction in patients with Duchenne muscular dystrophy. Am J Cardiol. 89:2002;838-841.
4. Farah M.G., Evans E.B., Vignos P.J. Jr. Echocardiographic evaluation of left ventricular function in Duchenne's muscular dystrophy. Am J Med. 69:1980;248-254.
5. Takenaka A., Yokota M., Iwase M., et al. Discrepancy between systolic and diastolic dysfunction of the left ventricle in patients with Duchenne muscular dystrophy. Eur Heart J. 14:1993;669-676.
6. Backman E., Nylander E. The heart in Duchenne muscular dystrophy: A non-invasive longitudinal study. Eur Heart J. 13:1992;1239-1244.
7. Melacini P., Fanin M., Danieli G.A., et al. Cardiac involvement in Becker muscular dystrophy. J Am Coll Cardiol. 22:1993;1927-1934.
8. Nigro G., Comi L.I., Politano L., et al. Evaluation of the cardiomyopathy in Becker muscular dystrophy. Muscle Nerve. 18:1995;283-291.
9. Saito M., Kawai H., Akaike M., et al. Cardiac dysfunction with Becker muscular dystrophy. Am Heart J. 132:1996;642-647.
10. Hoogerwaard E.M., de Voogt W.G., Wilde A.A., et al. Evolution of cardiac abnormalities in Becker muscular dystrophy over a 13-year period. J Neurol. 244:1997;657-663.
11. Boland B.J., Silbert P.L., Groover R.V., et al. Skeletal, cardiac, and smooth muscle failure in Duchenne muscular dystrophy. Pediatr Neurol. 14:1996;7-12.
12. Melacini P., Vianello A., Villanova C., et al. Cardiac and respiratory involvement in advanced stage Duchenne muscular dystrophy. Neuromuscul Disord. 6:1996;367-376.
13. Koyama J., Ray-Sequin P.A., Davidoff R., et al. Usefulness of pulsed tissue Doppler imaging for evaluating systolic and diastolic left ventricular function in patients with AL (primary) amyloidosis. Am J Cardiol. 89:2002;1067-1071.
14. Miller S., Simonetti O.P., Carr J., et al. MR Imaging of the heart with cine true fast imaging with steady-state precession: Influence of spatial and temporal resolutions on left ventricular functional parameters. Radiology. 223:2002;263-269.
15. Ishikawa Y., Bach J.R., Minami R. Cardioprotection for Duchenne's muscular dystrophy. Am Heart J. 137:1999;895-902.
16. Kober L., Torp-Petersen C., Carlsen J.E., et al. A clinical trial of the angiotensin-converting-enzyme inhibitor, trandolapril in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med. 333:1995;1670-1676.
17. Pfeffer M.A., Braunwald E., Moye L.A., et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction: Results of the Survival and Ventricular Enlargement Trial. N Engl J Med. 327:1992;669-677.
18. Thuillez C., Richer C., Loueslati H., et al. Systemic and regional haemodynamic effects of perindopril in congestive heart failure. J Cardiovasc Pharmacol. 15:1990;527-535.
19. The effect of enalapril on survival in patients with reduced left ventricular ejection fraction and congestive cardiac failure. N Engl J Med. 325:1991;293-302.
20. Anonymous. The cardiac insufficiency bisoprolol study II (CIBIS II): A randomized trial. Lancet 1999, 11:138-142.
21. MacMahon S., Sharpe N., Doughty R., et al. Randomized, placebo-controlled trial of carvedilol in patients with congestive heart failure due to ischaemic heart disease. Lancet. 349:1997;375-380.
22. Hjalmarson A., Goldstein S., Fagerberg B., et al. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL randomized intervention trial in congestive heart failure (MERIT-HF). Lancet. 353:1999;2001-2007.
23. McMurray J.J. Major beta-blocker mortality trials in chronic heart failure: A critical review. Heart. 82:(Suppl. IV):1999;IV14-IV22.
24. Zannad F., Alla F., Dousset B., et al. Limitation of excessive extracellular matrix turn over may contribute to survival benefit of spironolactone therapy in patients with congestive heart failure: Insights from the randomized aldosterone evaluation study (RALES). RALES Investigators Circ. 102:2001;2700-2706.
25. Locolley P., Safar M.E., Lucet B., et al. Prevention of aortic and cardiac fibrosis by spironolactone in old normotensive rats. J Am Coll Cardiol. 37:2001;662-667.
26. Eagle M., Baudouin S.V., Chandler C., et al. Survival in Duchenne muscular dystrophy: Improvements in life expectancy since 1967 and the impact of home nocturnal ventilation. Neuromuscul Disord. 12:2002;926-929.
27. Dubrovsky A.L., Angelini C., Bonifati D.M., et al. Steroids in muscular dystrophy: Where do we stand? Neuromuscul Disord. 8:1998;380-384.
28. Denis DUBOC et al., Trial of ACE inhibition in preventing onset of cardiomyopathy in Duchenne & Becker Muscular Dystrophy (Presentation to ENMC 107th Workshop 7-9th June 002: 'The management of cardiac complications in muscular dystrophy and myotonic dystrophy' [personal communication].
29. Crilley J.G., Boehm E.A., Rajagopalan B., et al. Magnetic resonance spectroscopy evidence of abnormal cardiac energetics in Xp21 muscular dystrophy. J Am Coll Cardiol. 15:2000;1953-1958.
30. Piccolo G., Azan G., Tonin P., et al. Dilated cardiomyopathy requiring cardiac transplantation as initial manifestation of Xp21 Becker type muscular dystrophy. Neuromuscul Disord. 4:1994;143-146.
31. Rees W., Schuler S., Hummel M., et al. Heart transplantation in patientswith muscular dystrophy associated with end-stage cardiomyopathy. J Heart Lung Transplant. 12:1993;804-807.
32. Mirabella M., Servidei S., Manfredi G., et al. Cardiomyopathy may be the only clinical manifestation in female carriers of Duchenne muscular dystrophy. Neurology. 43:1993;2342-2345.
33. Politano L., Nigro V., Nigro V., et al. Development of cardiomyopathy in female carriers of Duchenne and Becker muscular dystrophies. J Am Med Assoc. 275:1996;1335-1338.
34. Hoogerwaard E.M., van der Wouw P.A., Wilde A.A., et al. Cardiac involvement in carriers of Duchenne and Becker muscular dystrophy. Neuromuscul Disord. 9:1999;347-351.
35. Grain L., Cortina-Borja M., Forfar C., et al. Cardiac abnormalities and skeletal muscle weakness in carriers of Duchenne and Becker muscular dystrophies and controls. Neuromuscl Disord. 11:2001;186-191.
36. Olofsson B.O., Forsberg H., Andersson S., et al. Electrocardiographic findings in myotonic dystrophy. Br Heart J. 59:1988;47-52.
37. Groh W.J., Miriam R., Lowe M.S., et al. Severity of cardiac conduction involvement and arrhythmias in myotonic dystrophy type 1 correlates with age and CTG repeat length. J Cardiovasc Electrophysiol. 13:2002;444-448.
38. Hayashi Y., Ikeda U., Kojo T., et al. Cardiac abnormalities and cytosine-thyminie-guanine repeats in myotonic dystrophy. Am Heart J. 134:1997;292-297.
39. Milner M.R., Hawley R.J., Jachim M., et al. Ventricular late potentials in myotonic dystrophy. Ann Int Med. 115:1991;607-613.
40. Melacini P., Villanova C., Menegazzo E., et al. Correlation between cardiac involvement and the CTG trinucleotide repeat length in myotonic dystrophy. J Am Coll Cardiol. 25:1995;239-245.
41. Badano L., Autore C., Fragola P.V., et al. Left ventricular myocardial function in myotonic dystrophy. Am J Cardiol. 71:1993;987-991.
42. Finsterer J., Gharehbaghi-Schnell E., Stollberger C., et al. Relation of cardiac abnormalities and CTG-repeat size in myotonic dystrophy. Clin Genet. 59:2001;350-355.
43. Hawley R.J., Milner M.R., Gottdiener J.S., et al. Myotonic heart disease: A clinical follow-up. Neurology. 41:1991;259-262.
44. Clarke N.R.A., Kelion A.D., Nixon J., et al. Does cytosine-thymine-guanine (CTG) expansion size predict cardiac events and electr-ocardiographic progression in myotonic dystrophy? Heart. 86:2001;1-5.
45. Lazarus A., Varin J., Ounnoughene Z., et al. Relationship among electrophysiological findings and clinical status, heart function and extent of DNA mutation in myotonic dystrophy. Circulation. 99:1999;1041-1046.
46. Antonini G., Giubilei F., Mammaarella A., et al. Natural history of cardiac involvement in myotonic dystrophy: Correlation with CTG repeats. Neurology. 55:2000;1207-1209.
47. De Ambroggi L., Raisaro A., Marchiano V., et al. Cardiac involvement in patients with myotonic dystrophy: Characteristic features of magnetic resonance imaging. Eur Heart J. 16:1995;1007-1010.
48. Vignaux O., Lazarus A., Varin J., et al. Right ventricular MR abnormalities in myotonic dystrophy and relationship with intracardiac electrophysiology test findings: Initial results. Radiology. 224:2002;231-235.
49. Forsberg H., Olofsson B.O., Eriksson A., et al. Cardiac involvement in congenital myotonic dystrophy. Br Heart J. 63:1990;119-121.
50. Reardon W., Newcombe R., Fenton I., et al. The natural history of congenital myotonic dystrophy: Mortality and long term clinical aspects. Arch Dis Child. 68:1993;177-181.
51. Brockington M., Blade D.J., Prandini P., et al. Mutations in the fukutin-related protein gene (FKRP) cause a form of congenital muscular dystrophy with secondary laminin alpha-2 deficiency and abnormal glycosilation of alpha-dystroglycan. Am J Hum Gen. 69:2001;1189-1209.
52. Emery A.E.D., Dreifuss F.E. Unusual type of benign X-linked muscular dystrophy. J Neurol Neurosurg Psychiatry. 29:1966;338-342.
53. Bione S., Maestrini E., Rivella S., et al. Identification of a novel X-linked gene responsible for Emery-Dreifuss muscular dystrophy. Nat Genet. 8:1994;323-327.
54. Funakoshi M., Tsuchiya Y., Arahata K. Emerin and cardiomyopathy in Emery-Dreifuss muscular dystrophy [Review]. Neuromuscul Disord. 9:1999;108-114.
55. Merlini L., Granata C., Dominici P., et al. Emery-Dreifuss muscular dystrophy: Report of five cases of a family and review of the literature. Muscle Nerve. 9:1986;481-485.
56. Wehnert M., Muntoni F. 60th ENMC International Workshop: Non-X-linked Emery-Dreifuss muscular dystrophy 5-7 June 1998, Naarden, The Netherlands. Neuromuscul Disord. 9:1999;115-121.
57. Bonne G., Di Barletta M.R., Varnous S., et al. Mutations in the gene encoding lamin A/C cause autosomal dominant Emery-Dreifuss muscular dystrophy. Nat Genet. 21:1999;285-288.
58. Buckley A.E., Dean J., Mahy I.R. Cardiac involvement in Emery-Dreifuss muscular dystrophy: A case series. Heart. 82:1999;105-108.
59. Vohanka S., Vytopil M., Beanarik J., et al. A mutation in the X-linked Emery-Dreifuss muscular dystrophy gene in a patient affected with conduction cardiomyopathy. Neuromuscul Disord. 11:2001;411-413.
60. Van der Kooi A.J., van Meegen M., Ledderhof T.M., et al. Genetic localization of a newly recognized autosomal dominant limb-girdle muscular dystrophy with cardiac involvement (LGMD1B) to chromosome 1q11-21. Am J Hum Gen. 60:1997;891-895.
61. Fatkin D., MacRae C., Sasaki T., et al. Missense mutations in the rod domain of the lamin A/C gene as causes of dilated cardiomyopathy and conduction-system disease. N Engl J Med. 341:1999;1715-1724.
62. Becane H.M., Bonne G., Varnous S., et al. High incidence of sudden death with conduction system and myocardial disease due to lamin A and C gene mutation. Pacing Clin Electrophysiol. 23:2000;1661-1666.
63. Nelson S.D., Sparks E.A., Graber H.L., et al. Clinical characteristics of sudden death victims in heritable (Chromosome 1p1-1q1) conduction and myocardial disease. J Am Coll Cardiol. 32:1998;1717-1723.
64. Bharati S., Surawicz B., Vidaillet H.J. Jr, Lev M. Familial congenital sinus rhythm abnormalities: Clinical and pathological correlates. Pacing Clin Electrophysiol. 15:1992;1720-1729.
65. Bonne G., Mercuri E., Murchir A., et al. Clinical and molecular genetic spectrum of autosomal dominant Emery-Dreifuss muscular dystrophy due to mutations of the lamin A/C gene. Ann Neurol. 48:2000;170-180.
66. DiBarletta R.M., Ricci E., Galluzzi G., et al. Different mutations in the LMNA gene cause autosomal dominant and autosomal recessive Emery-Dreifuss muscular dystrophy. Am J Genet. 66:2000;1407-1412.
67. Graham R.M., Owens W.A. Pathogenesis of inherited forms of dilated cardiomyopathy. N Engl J Med. 341:1999;1759-1762.
68. Davies M.J. The cardiomyopathies: An overview. Heart. 83:2000;469-474.
69. Bushby K.M.D. The limb-girdle muscular dystrophies. Emery A.E.H. The muscular dystrophies. 2001;109-136 Oxford University Press, Oxford.
70. Bushby K.M.D. The limb-girdle muscular dystrophies: Multiple genes, multiple mechanisms. Hum Mol Genet. 8:1999;1875-1882.
71. Politano L., Nigro V., Passamano L., et al. Evaluation of cardiac and respiratory involvement in sarcoglycanopathies. Neuromuscul Disord. 11:2001;178-185.
72. van der Kooi A.J., de Voogt W.G., Barth P.G., et al. The heart in limb-girdle muscular dystrophy. Heart. 79:1998;73-77.
73. Poppe M.J., Eagle M., Bourke J., Bullock R., Cree L., Buddles M., Bushby K. Respiratory and cardiac involvement are an important part of limb-girdle muscular dystrophy. Neuromuscul Disord. 12:2002;732-733.
74. Brockington M., Yuva Y., Prandini P., et al. Mutations in the fukutin-related protein gene (FKRP) identify limb-girdle muscular dystrophy 21 as a milder allelic variant of congenital muscular dystrophy MDC1C. Hum Mol Gen. 10:2001;2851-2859.
75. Pollitt C., Anderson L.V., Pogue R., Davison K., Pyle A., Bushby K.M.D. The phenotype of calpainopathy: Diagnosis based on multidisciplinary approach. Neuromuscul Disord. 11:2001;287-296.
76. Gnecchi-Ruscone T., Taylor J., Mercuri E., et al. Cardiomyopathy in Duchenne, Becker, and sarcoglycanopathies: A role for coronary dysfunction? Muscle Nerve. 22:1999;1549-1556.
77. De Visser M., de Voogt W.G., la Riviere G.V. The heart in muscular dystrophy, fascioscapulohumeral dystrophy and Bethlem myopathy. Muscle Nerve. 15:1992;591-596.
78. Faustmann P.M., Farahati J., Rupilius B., et al. Cardiac involvement in fascio-scapulo-humeral muscular dystrophy: A family study using Thallium-201 single-photon-emission-computer tomography. J Neurol Sci. 144:1996;59-63.
79. Baldwin B.J., Talley R.C., Johnson C., Nutter D.O. Permanent paralysis of the atrium in a patient with fascioscapulohumeral muscular dystrophy. Am J Cardiol. 31:1973;649-653.
80. Kimura T., Moriwaki T., Sawada J., et al. A family with fascioscapulohumeral muscular dystrophy and hereditary long-QT syndrome [Japanese]. Rinsho Shinkeigaku. 37:1997;690-692.
81. Laforet P., de Toma C., Eymard B., et al. Cardiac involvement in genetically confirmed fascioscapulohumeral muscular dystrophy. Neurology. 51:1998;1454-1456.
82. Woelfel A., Cascio W., Smith S.W. Cerebral embolization in two young patients with fascioscapulohumeral muscular dystrophy and atrial dysrhythmias. Am Heart J. 118:1989;632-633.
83. Stevenson W.G., Perloff J.K., Weiss J.N., et al. Fascioscapulohumeral muscular dystrophy: Evidence for selective genetic electrophysiologic cardiac involvement. J Am Coll Cardiol. 15:1990;292-299.